Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
Year: 2026
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Xiangmin Wang, Qing Zhang, Dongmei Yan, Yawen Wei, Hongzhi Geng, Kang Rong, Jiahui Sun, Xicheng Chen, Meina Zhang, Peiling Zhang, Yujie Li, Ruiyang Xie, Han Sun, Ziyuan Shen, Hongyuan Zhou, Tianci Li, Jiaoli Zhang, Yicheng Zhang, Tongcun Zhang, Linyan Xu, Ting Niu, Wenbin Qian, Qingyun Wu, Liang Huang, Caixia Li, Wei Sang
Institutions: Xuzhou Medical College, Yancheng First People's Hospital, First Affiliated Hospital of Soochow University, Tongji Hospital, Huazhong University of Science and Technology, Affiliated Hospital of Xuzhou Medical College, Wuhan University of Science and Technology, Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy, Second Affiliated Hospital of Zhejiang University, Zhejiang University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G311601133, G8741770090
OpenAlex ID: W7170072800